FLIXONASE AQUEOUS NASAL SPRAY

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

FLUTICASONE PROPIONATE

متاح من:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC رمز:

R01AD08

الشكل الصيدلاني:

SUSPENSION

تركيب:

FLUTICASONE PROPIONATE 0.05 G / 100 G

طريقة التعاطي:

NASAL

نوع الوصفة الطبية :

Not required

المصنعة من قبل:

GLAXO WELLCOME SA, SPAIN

المجموعة العلاجية:

FLUTICASONE

المجال العلاجي:

FLUTICASONE

الخصائص العلاجية:

Self medication:Prophylaxis and treatment of seasonal allergic rhinitis including hay fever in adults.By Physicians order:Prophylaxis and treatment of seasonal allergic rhinitis including hay fever in children of the age of 4 years and above and perennial rhinitis in adults and children of the age of 4 years and above.

تاريخ الترخيص:

2023-05-31

نشرة المعلومات

: ךיראת
לירפא
2018
:ןודנה
FLIXONASE AQUEOUS NASAL SPRAY
/ זנוסקילפ
סיסרת
ל
ףא
FLUTICASONE PROPIONATE 0.05 GR / 100 GR SUSPENSION
ה/דבכנ ה/אפור
,ה/דבכנ ת/חקור
תרבח
ג
ןיילקתימסוסקל
מ"עב לארשי
GSK) ( ןכרצלו אפורל םינולעה ןוכדע לע עידוהל
תשקבמ
לש
ףאל סיסרת זנוסקילפ
רישכתל המושרה היוותהה
:לארשיב
Prophylaxis and treatment of seasonal allergic rhinitis including
hayfever, and perennial rhinitis.
Perenial rhinitis in children of the age of 4 years
:אפורל ןולעב םיאבה םיפיעסב ושענ
םייתוהמ םינוכדע
4.8 UNDESIRABLE EFFECTS
…
RESPIRATORY, THORACIC
AND MEDIASTINAL
DISORDERS
Epistaxis
Very common
Nasal dryness, nasal irritation, throat dryness, throat
irritation
Common
Nasal septal perforation
Very rare
NASAL ULCERS
UNKNOWN
… ושענ םייתוהמ םינוכדע םיפיעסב
אבה
םי
: ןכרצל ןולעב
4
יאוול תועפות .
... תועפות) העודי הניא ןתוחיכשש יאוול
תועפות
(העבקנ םרט ןתוחיכשש

תשטשוטמ הייאר ןוגכ םייניעב תויעב

ףאב םיעצפ
...
יונישה טוריפו תוהמ לע עדימל
םי ,
ןכרצל ןולעו אפורל ןולע האר
םיפרוצמ
ו
ילע
םה
םייונישה םינמוסמ
ארקמ
םינוכדעל
םינמוסמה
:
תפסות
הרמחה
-
בתכ
לוחכ
-
ןמוסמ
בוהצב
רקרמ
ןולעה
אפורל
ןולעהו
ןכרצל
וחלשנ
םוסרפל
רגאמב
תופורתה
רתאבש
דרשמ
תואירבה
:
https://www.old.health.gov.il/units/pharmacy/trufot/index.asp?safa=h
ןתינו
םיספדומ םלבקל
לע
-
תרבחל הינפ ידי
לזב 'חר ןיילקתימסוסקלג
25
:ןופלטב הוקת חתפ
03-9297100
.
,הכרבב
ןזור תירש
הנוממ תחקור

خصائص المنتج

_Page 1 of 9 _
Flixonase Aqueous Nasal Spray
1
NAME OF THE MEDICINAL PRODUCT
Flixonase
Aqueous Nasal Spray
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Aqueous suspension of 0.05% micronised fluticasone propionate.
Each actuation contains 50 micrograms of fluticasone propionate.
For full list of excipients see section 6.1
3
PHARMACEUTICAL FORM
Nasal spray, suspension
4
CLINICAL PARTICULARS
4.1
Therapeutic indications
Self medication:
Prophylaxis and treatment of seasonal allergic rhinitis including hay
fever in adults.
By Physicians order:
Prophylaxis and treatment of seasonal allergic rhinitis including hay
fever in children of
the age of 4 years and above and perennial rhinitis in adults and
children of the age of 4
years and above.
4.2
Posology and Method of Administration
Flixonase Aqueous Nasal Spray is for administration by the intranasal
route only.
Contact with the eyes should be avoided.
Adults and children over 12 years of age:
For the prophylaxis and treatment of seasonal allergic rhinitis and
perennial rhinitis.
_Page 2 of 9 _
Two sprays into each nostril once a day, preferably in the morning. In
some cases two
sprays into each nostril twice daily may be required. Once symptoms
are under control a
maintenance dose of one spray per nostril once a day may be used. If
symptoms recur
the dosage may be increased accordingly. The minimum dose should be
used at which
effective control of symptoms is maintained. The maximum daily dose
should not
exceed four sprays into each nostril.
Elderly patients:
The normal adult dosage is applicable.
Children under 12 years of age:
For the prophylaxis and treatment of seasonal allergic rhinitis and
perennial rhinitis in
children aged 4-11 years a dose of one spray into each nostril once
daily preferably in
the morning is recommended. In some cases one spray into each nostril
twice daily may
be required. The maximum daily dose should not exceed two sprays into
each nostril.
The minimum dose should be used at which effective control of symptoms
is
maintained.
Flixonase Aqueo